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Abstract 
The implantation of a mechanical circulatory device for end-stage ventricular 
failure is a possible therapeutic approach in adult and pediatric cardiac 
surgery and cardiology. The aim of this article is to present mechanical 
circulatory assist devices used in infants and children with special emphasis 
on extracorporeal membrane oxygenation, Berlin Heart assist device, 
centrifugal pump and Medos assist device. The success of long-term support 
with implantable ventricular assist devices in adults and children has led to 
their increasing use as a bridge to transplantation in patients with otherwise 
non-treatable left ventricular failure, by transforming a terminal phase heart 
condition into a treatable cardiopathy. Such therapy allows rehabilitation of 
patients before elective cardiac transplantation (by removing contraindications 
to transplantation mainly represented by organ impairment) or acting as a 
bridge to recovery of the native left ventricular function (depending on 
underlying cardiac disease). Treatment may also involve permanent device 
implantation when cardiac transplantation is contraindicated. Indications for 
the implantation of assisted circulation include all states of cardiac failure that 
are reversible within a variable period of time or that require heart 
transplantation. This article will address the current status of ventricular assist 
devices by examining historical aspects of its development, current technical 
issues and clinical features of pediatric ventricular assist devices, including 
indications and contraindications for support. 
MeSH: Ventricular assist device, ECMO, Centrifugal pump, Heart failure, 
Medos, HeartMate, Berlin Heart, Thoratec, Jarvik 2000 
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Definition 
A ventricular assist device is a pump that is attached between the heart and 
the aorta or pulmonary artery which helps to circulate a person's blood when 
the heart can no longer adequately support circulation. The aim of such a 
device is to unload the heart and to provide an adequate peripheral circulation 
with sufficient organ function. In reducing cardiac work and oxygen 
consumption the required energy for repair processes and synchronized heart 
performance can be spared and leads to a quicker recovery of “stunned” 
myocardial segments.1 
There is great interest in implanting ventricular assist devices for circulatory 
support in children. Ventricular assist devices of various design and function 
principles have been used for temporary support of failing hearts aiming at 
myocardial recovery or keeping the patient alive until later transplantation. 
Despite improvements in operative techniques, management of 
cardiopulmonary bypass and myocardial protection, myocardial dysfunction 
can occur after operation for complex congenital heart disease with 
involvement of the left and right ventricle.2 Approximately 5 % of children 
undergoing open heart surgery need mechanical circulatory assistance.3 
Reports of ventricular assist device support in smaller children (< 20 kg) 
remain limited.2 This is partly due to technical considerations, for example, low 
flow rates may be a risk for thromboembolic complications when adult-sized 
systems are applied in children.4 Moreover, left ventricular assist devices can 
only be inserted when intracardiac shunts are closed, and right ventricular 
assist devices require some kind of pulmonary valve.5 
Owing to the lack of sufficiently small, commercially available valves, and the 
tendency for thrombus formation in small pumps, the attempt to scale down 
adult blood pumps for pediatric use remains difficult. However, the need for 
pediatric ventricular assist devices is increasing: first owing to the possibility of 
corrective operations for many previously inoperable forms of complex 
congenital heart disease in younger and smaller patients than before, and 
second, to the success of pediatric heart transplantations which leads to an 
increase of the number of transplant candidates and of the waiting time for the 
rare donor organs. 
A surgical infrastructure consisiting of a well equipped neonatal and pediatric 
intensive care unit and a permanently accessible laboratory for monitoring 
coagulation status is needed to obtain satisfactory results. 
 
History of ventricular assist devices in adults 
To repair and replace a heart a medical dream. The first concept of circulatory 
support as a prosthesis that could replace the heart and sustain sufficient flow 
for peripheral circulation was probably postulated by the French physician 
Legallois in 1812.6,7 In 1849 Loebell began his work on an isolated kidney 
model and in 1854 Claude Bernard conducted the famous foie lavé 
experiment.8 Between 1848 and 1858 Brown-Séquard demonstrated the need 
to oxygenate the blood that was used as perfusion solution. In 1868 Ludwig 
and Schmidt achieved extracorporeal oxygenation, using venous blood-gurgle 
in a flask. Von Schroeder built the first steady-flow bubble oxygenator in 1882; 
Frey and Gruber developed the first film oxygenator in 1885. In 1916 McLean 
discovered heparin, which allowed the blood to circulate through artificial 
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tubes for a longer time. Dale and Schuster in 1928 were the first to construct a 
diaphragm pump. The transatlantic flyer Lindbergh, spurred on by his sister-
in-law's heart disease, together with Carrel, developed an oxygenating pump, 
and demonstrated the possibility of extracorporeal perfusion. In 1934 
DeBakey introduced the concept of a continuous flow blood transfusion 
instrument that was a simple roller pump.9 In 1937 Gibbon described a heart-
lung machine and reported on first animal experiments. In 1954 Gibbon 
carried out the first successful human open heart operation (atrium septal 
defect closure on a 18 year old girl) with the use of the heart-lung 
machine.10,11 In 1957 Akutsu and Kolff implanted two compact pumps into a 
dog's chest following cardiectomy. In 1961 Dennis performed a left heart 
bypass by inserting cannulae in the left atrium and returning blood through the 
femoral artery.12 
In 1962 Kolff and Moulopoulos developed the intraaortic balloon pump and 
demonstrated their value in an animal model.13 In 1966 Kantrowitz performed 
its first clinical application in a 45-year-old woman in cardiogenic shock.14 In 
1963 Spencer supported a 6-year old girl after an operation to repair a 
ventricular septal defect.15 In 1964 Liotta published results from the first 
clinical implantation of a pulsatile left ventricular assist device.9 In 1968 
Raffert reported on a centrifugal pump for blood pumping. In 1969 Cooley 
implanted the first artificial heart, keeping the patient alive for over sixty hours. 
The Jarvik-7 artificial heart, named after its designer Robert K. Jarvik, an 
American physician, was first used during the early 1980s16 and in 1982 a 
team led by DeVries of the University of Utah implanted the Jarvik-7 for the 
first time. The patient survived with a Jarvik-7 for 112 days. At that time 
patients were anchored to large consoles with poor quality of life. The Jarvik-7 
was further developed by Cardiowest and is nowadays known as CardioWest 
Artificial Heart. 
The Novacor LVAD (Baxter Corp., Oakland, CA), initially designed for 
permanent use, has been used as a bridge to transplantation since 1984. 
Unlike Jarvik this ventricle is placed heterotopically below the diaphragm 
allowing the natural heart to remain in place.17 Early systems required a large 
console but eventually, a wearable version, supported by a small electronic 
controller and batteries worn on a belt, was introduced in 1993.18–20 
Since 1987 centrifugal Biomedicus pump started in clinical use. In 1988 
“Berlin Heart” (Berlin Heart Institut, Mediport Kardiotechnik Berlin, Germany) 
pumps became available.21 The first HeartMate ventricular assist devices 
were implanted in 1992. The Medos ventricular assist device has been in 
clinical use since 1994 with the first implantation in an adult patient performed 
by Sievers. In 1994 Abiomed BVS 5000 ventricular assist device became 
available at Hahnemann University Hospital, Philadelphia, PA.22 
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History of ventricular assist devices in children 
Despite the success of ventricular assist devices in adults, little has been 
done to develop similar devices for pediatric patients. Scientific and 
engineering efforts have all been focused on heart-lung machines and 
circulatory support systems for adults. Indeed, the first neonatal oxygenator 
was released in the 1990s.23 In 1973 Soeter described the use of 
extracorporeal life support in a 4-year-old girl with severe hypoxemia after 
repair of Tetralogy of Fallot.24 The system employed used a rotary pump with 
a membrane oxygenator and a heat exchanger. The patient was weaned from 
the support within 48 hours and was discharged on the 13th postoperative 
day. In 1974 Bartlett reported the use of extracorporeal membrane 
oxygenation in pediatric patients with respiratory failure or after repair of 
congenital heart disease.25,26 Hill and Pyle described two patients who had 
severe postcardiotomy dysfunction, and who both died despite the 
implantation of extracorporeal membrane oxygenation.27,28 In 1989 the 
Extracorporeal Life support Organization was founded as an organization to 
study the clinical use of extracorporeal membrane oxygenation and 
maintained the Extracorporeal Life support Organization registry which 
compiles data on the use of extracorporeal membrane oxygenation. These 
data show that pediatric cardiac support has accounted for approximately 13 
% of total extracorporeal membrane oxygenation utilization.29 
In 1980 Pollock reported the first use of an intraaortic balloon pump in 
children,30 when a 6 year old child was pumped following a cardiac operation. 
In 1983 Veasy reported the use of small balloon catheters in 15 children.31 
Despite the commercial availability of pediatric-sized balloon catheters in the 
early 1980s, intraaortic balloon pump for children and infants has not become 
widespread. 
The Thoratec ventricular assist devices (Thoratec Laboratories Corporation, 
Pleasanton, CA) have been available since the early 1980s, and can be 
implanted in children and adolescents.32 Ventricular assist devices using 
centrifugal pumps have been used for infants and children since the 
development of a pediatric centrifugal pump head by Medtronic Bio-Medicus 
(Eden Prairie, MN) in the late 1980s.33–35 
In 1992, the “Berlin Heart” offered the first commercially available system with 
miniaturized paracorporeal pumps and cannulae.21 In the same year an 8-
year-old child was supported with a Berlin Heart for 8 days in intractable 
circulatory failure, followed by a successful transplantation and an uneventful 
postoperative course.21 The first implantation of a Medos ventricular assist 
device as a bridge to transplant took place in 1994.36 
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Types of ventricular assist devices 
The use of temporary ventricular assist devices in adults and children is now 
routine, and the development of permanent ventricular assist devices and 
total artificial hearts is the subject of ongoing research in the United States, 
Europe, Australia, Japan, China, Korea, Russia and other countries. A 
detailed description of all these devices is beyond the scope of this document 
and only those with significant design features or devices sufficiently 
developed to be nearing clinical trials will be discussed. 
Blood pumps are divided into two main groups according to the nature of their 
flow: nonpulsatile and pulsatile pumps. Nonpulsatile pumps produce flat 
continuous flow in which there is no pulse pressure. These pumps include 
centrifugal pumps and axial flow pumps. As a bridge to cardiac transplantation 
in adults the most widely used devices are those with pulsatile flow (Abiomed, 
Thoratec, Novacor, Berlin Heart, Heart Mate, Medos). In these devices blood 
is forced by positive pressure produced by the pump, squeezing the artificial 
ventricle which is contained within a rigid shell. Overall survival rates range in 
non-pulsatile centrifugal pumps is between 25 - 40 %2,37,38,39 and in the 
pulsatile pneumatic or electromechanical pumps between 25 - 80 %.40,39,38 
Different devices function similarily. Blood is generally drawn at left/right 
atrial/ventricular level, run into an artificial ventricle and is reintroduced at 
aortic and/or pulmonary level. With these systems it is possible to maintain a 
paraphysiological circulation for long periods of time. 
Energy sources are pneumatic for devices like Thoratec, Abiomed, Medos, 
Berlin Heart, Heart Mate and electric for extracorporeal membrane 
oxygenation, Novacor and Heart Mate. The patient's hemodynamic 
characteristics determine the use of mono- or biventricular assist devices. 
Implantation of left ventricular assist devices is contraindicated in the 
presence of high pulmonary vascular resistance, shunting or if, shortly after 
implantation of left ventricular assist device, fall in cardiac index, reduced 
diuresis and central venous pressures > 25 mmHg are recorded: in these 
cases a biventricular device is needed. In children such problems as low 
cardiac output syndrome and right heart failure including pulmonary 
vasoreactive crises after cardiac operations are common.4 
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Intraaortic balloon pump 
 
 
Figure 1 intraaortic balloon pump 
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Extracorporeal membrane oxygenation (ECMO) 
 
 
Figure 2 extracorporeal membrane oxygenation in a 7 days old child after 
Damus-Kaye-Stansel operation 
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Centrifugal pump ventricular assist device 
 
 
Figure 3 Bio-Pump blood pump 
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Berlin Heart 
 
 
Figure 4 Berlin Heart ventricular 
assist device 
 
Figure 5 Berlin Heart pediatric pump 
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Medos 
 
 
Figure 6 Medos ventricular assist device 
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Thoratec 
 
 
Figure 7 Thoratec pump 
 
A Fuchs and H Netz. Ventricular assist devices in pediatrics. Images Paediatr Cardiol. 2001 Oct-Dec; 
3(4): 24–54.  
 35 
 
Novacor 
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HeartMate 
 
 
Figure 8 HeartMate pneumatic ventricular assist device 
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Abiomed 
 
 
Figure 9 Abiomed ventricular assist device 
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Jarvik 2000 
 
 
Figure 10 Jarvik 2000 
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Table 1 Technical details of ventricular assist devices (summarised) 
 
 
 
This system has the potential for use as a permanent ventricular assist device 
or as a bridge to transplantation or recovery in adults and pediatric patients 
needing left ventricular support exclusively. 
 
Indications and contraindications for the implantation of ventricular 
assist devices 
No precise guidelines for the implantation of ventricular assist devices in 
pediatrics exist. The decision for implantation of a ventricular assist device 
can only be made by assessing the individual clinical situation of each patient 
with the help of a careful diagnostic approach. The indications for the use of 
ventricular assist device in pediatric cardiology depend on individual units’ 
experiences. 
The indications for the implantation of ventricular assist devices can be 
divided in cases of patients without operation like myocarditis, endocarditis, 
neoplasm or Eisenmenger syndrome, and postoperative indications with 
deterioration in preoperative ventricular function exacerbated by surgery (for 
example Bland-White Garland syndrome, hypoplastic left heart syndrome, 
neoplasm, postoperative change of hemodynamics, arterial switch in 
transposition of the great arteries after the neonatal period, secondary arterial 
switch after atrial switch or congenitally corrected transposition of the great 
arteries, Fontan or Fontan-type procedures with postoperative left ventricular 
deterioration, pulmonary hypertensive crisis refractory to prostayclin or nitric 
monoxide treatment, right ventricular failure in tetralogy of Fallot, myocardial 
failure from prolonged cross-clamp and cardiopulmonary bypass time, 
Kawasaki disease or procedures with intraoperative complications).5 
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Surveillance before implantation of a ventricular assist device is directed at 
registering onset of premonitory manifestations of potentially untreatable low 
flow rates. Ventricular arrhythmias, hypoxemia and renal dysfunction 
constitute prodromes of reduced flow and can be taken as indication criteria 
for ventricular assist devices. Organ dysfunction is also one of the main 
problems in ventricular assistance owing to the impossibility of determining 
reversal of organ damage. Contraindications for the implantation of a 
ventricular assist device include severe renal and hepatic failure, irreversible 
septic shock, severe neurological damage and hemorrhage.83 
Contraindications for implantation of circulatory assist systems are the same 
as for cardiac transplantation as cardiac recovery is uncertain. Multiorgan 
failure is a clear contraindication, but early states of multiorgan failure can be 
reversed by circulatory mechanical assistance. Coagulation disorders, 
intracranial bleeding and severe neurological complications preclude the 
implantation of assist devices. Acute or chronic infection impair the 
implantation of a mechanical assist system,84 but the implantation of an assist 
system in viral myocarditis is possible.85 Patients after a prolonged run of 
cardiopulmonary bypass seem to be less favourable for mechanical assist as 
hemostasis is crucial for eventual outcome. Selection of the most appropriate 
support system may be decisive for survival of critically ill infants with an 
otherwise untreatable cardiac condition. 
 
Intraaortic balloon pump 
In predominantly right ventricular failure which is often observed in congenital 
heart disease, intraaortic balloon pump is ineffective. In addition, myocardial 
ischemia for which intraaortic balloon pumps are useful is an uncommon 
cause of congestive heart failure in pediatrics. Intraaortic balloon pump 
appears of therapeutical value for children with a more moderate form of left 
ventricular dysfunction, but severe cases require the implantation of a left 
ventricular assist device. 
A general indication is low cardiac output despite adequate treatment evinced 
by poor peripheral perfusion (low mean aortic pressure), metabolic acidosis, 
mixed venous pO2 < 25 mmHg, urine output < 1 ml/kg/h and left atrial 
pressure > 20 mmHg.41 Malignant ventricular arrhythmias due to low coronary 
blood flow and high catecholamine support can profit from intraaortic balloon 
pump. Contraindications are patent ductus arteriosus, recent coarctation or 
aortic arch repair and significant aortic valve insufficiency. 
 
Extracorporeal membrane oxygenation 
Biventricular support with extracorporeal membrane oxygenation23 is the 
predominantly used ventricular assist device in children with heart disease 
who have failed conventional medical treatment. The use of extracorporeal 
membrane oxygenation has been proven to be life-saving in children with 
myocardial failure, because of the advantages of rapid priming of both right 
and the left heart and support of pulmonary function. Hypoxia and pulmonary 
hypertension are indications for circulatory support with extracorporeal 
membrane oxygenation.86 
A Fuchs and H Netz. Ventricular assist devices in pediatrics. Images Paediatr Cardiol. 2001 Oct-Dec; 
3(4): 24–54.  
 41 
Postoperative support is established for failure to wean from cardiopulmonary 
bypass, cardiogenic shock or cardiac arrest after cardiac surgery.52,55,87,88 
Treatment with high-frequency ventilation, nitric oxide and liquid ventilation 
can fail when severe hypoxia occurs in the setting of congenital heart disease. 
Extracorporeal membrane oxygenation is the method of choice in the 
persistence of intracardiac shunts or in cases of profound respiratory 
insufficiency accompanying heart failure. Examples of congenital heart 
diseases often requiring postoperative circulatory support like extracorporeal 
membrane oxygenation are congenital heart diseases with shunts, total 
anomalous pulmonary venous connection because of preoperative respiratory 
problems and postoperative pulmonary hypertensive crisis.64 
When myocardial recovery can be expected and immediate weaning of the 
extracorporeal circuit is not possible, extracorporeal membrane oxygenation is 
the method of choice for a few days after open heart surgery, for example 
after switch operation, total anomalous pulmonary vein drainage, Bland White 
Garland syndrome or after heart transplantation.89 
Ishino recommends extracorporeal membrane oxygenation as a first choice 
for biventricular support after arterial switch operation, particularly in unusual 
and complex coronary patterns.64,90 When right or biventricular failure 
develops in infants with imbalanced ventricles, extracorporeal membrane 
oxygenation is the optimal method of circulatory support. In cases of lung 
failure and pulmonary hypertension beside underlying cardiac diseases, 
implantation of extracorporeal membrane oxygenation should be favoured.91 
Pulmonary hypertension is a contraindication for the implantation of a left 
ventricular assist device because of the high risk for right ventricular failure 
after left ventricular assist device insertion.83 
In a study involving cardiac and non-cardiac patients, indications for 
extracorporeal membrane oxygenation were hypoxia (36 %), cardiac arrest 
(24 %) and failure to wean from cardiopulmonary bypass (14 %).23 Several 
studies emphasize failure to wean from cardiopulmonary bypass as a 
negative prognostic indicator,23,52,62,88 whereas other studies could not find a 
negative impact.55,57,92 
Several studies stress the importance of early institution of extracorporeal 
membrane oxygenation, before prolonged periods of low cardiac output result 
in severe organ damage. Low cardiac output in congenital heart disease with 
shunted single ventricle physiology, including patients with hypoplastic left 
heart syndrome after neonatal palliation, is an indication for implantation of 
extracorporeal membrane oxygenation.48,57,88 Blood flow through shunts 
should be limited to ensure systemic perfusion and to avoid excessive 
pulmonary “flooding”. Contraindications include malignancy, multisystem 
organ failure, prematurity and severe central nervous system damage.48,51,56,88 
 
Centrifugal pump ventricular assist device 
The clinical application of centrifugal ventricular assist devices has generally 
been limited to adults and large pediatric patients, but neonates and small 
pediatric patients requiring ventricular support post-cardiopulmonary bypass 
are also well supported by a centrifugal ventricular assist device. 
In a major study,2,37 the majority of patients receiving Biomedicus supporting 
systems had undergone palliative or reparative open heart operations (for 
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cyanotic heart vitia with increased or decreased pulmonary flow, right or left 
sided obstructive lesions, Bland White Garland syndrome) or transplantation, 
and could not be weaned from cardiopulmonary bypass, a subset therefore 
presenting with low cardiac output following satisfactory weaning. Only rarely 
was low cardiac output due to myocarditis or cardiomyopathy a primary 
indication.93 According to Konertz, indications for implantation of centrifugal 
pumps are acute (nonsurgical) cardiogenic shock, rescue postcardiotomy 
support, low cardiac output after long pump runs in complex cardiac 
reconstructions and bridge to transplantation.84 Centrifugal ventricular assist 
device can be applied in univentricular circulation, for example after Norwood 
operation for hypoplastic left heart syndrome or after bidirectional 
cavopulmonary shunts.2 Contraindications are the same as mentioned for 
extracorporeal membrane oxygenation. 
 
Novacor 
The main indications for implantation of Novacor systems are ischemic or 
idiopathic cardiomyopathy, acute myocardial infarction and myocarditis in 
adults.19,74,75 
 
Berlin Heart 
Indications for implantation of a Berlin Heart assist device include bridge to 
transplant in chronic myocardial diseases or end stages of congenital heart 
disease, rescue therapy after operation for congenital heart disease, acute 
viral myocarditis,21 cardiomyopathies, myocardial infarction, repeated 
cardiopulmonary resuscitation and postcardiotomy cardiogenic shock.63,90 The 
best candidates for its application are patients with biventricular hearts without 
intracardiac shunting.91 There is the possibility of switching from biventricular 
assist device to extracorporeal membrane oxygenation for easier weaning 
once normal functional patterns of the initially akinetic ventricles are 
observed.63 Contraindications are the same as mentioned for extracorporeal 
membrane oxygenation. 
 
Thoratec 
Patients receiving a Thoratec assist device suffer from various forms of end-
stage cardiomyopathies, myocarditis, underlying congenital defects 
(transposition of the great arteries, Ebstein's anomaly, tetralogy of Fallot) and 
post-cardiotomy cardiac failure.32 
 
Medos 
Indications for implantation of Medos ventricular assist device include heart 
failure after surgery for congenital heart diseases, cardiomyopathy or acute 
myocarditis, low cardiac output or cardiac arrest at the intensive care unit 
following successful weaning from cardiopulmonary bypass.36 In a study at 
the Charité, Germany, indications were cardiogenic shock and postoperative 
failure (57 % recovery). Patients in cardiogenic shock had high mortality, only 
a minority could be successfully weaned or transplanted. In contrast patients 
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with postcardiotomy heart failure had a success rate of 50 % either by 
weaning or by transplantation.36,68 Contraindications are multiorgan failure, 
severe coagulopathy, intracranial hemorrhage, neurological impairment and 
sepsis.36 
 
HeartMate 
Severe cardiac failure in chronic dilated cardiomyopathy, resuscitation, acute 
myocarditis, and Ebstein's anomaly are reasons for implantation of HeartMate 
ventricular assist device in adolescent and pediatric patients.76 
 
Abiomed BVS 5000 
The typical indications are failure to wean from cardiopulmonary bypass, 
precardiotomy shock, viral myocarditis, myocardial infarction and intractable 
arrhythmia.22,94 Abiomed BVS 5000 is predominantly used for short-term 
mechanical support in postcardiotomy patients in cardiogenic shock expecting 
myocardial.79,56 
 
Predictive factors 
The timing of the installation of a ventricular assist device is crucial for 
outcome of patients needing circulatory support. Several studies have shown 
that survival is better when extracorporeal life support is instituted after 
successful weaning from cardiopulmonary bypass.52,53,56,57,88 Therefore the 
distinction between postcardiotomy patients on ventricular assist device 
because of failure to wean from cardiopulmonary bypass or because of 
myocardial dysfunction after successful weaning is important. Several studies 
group all sorts of postcardiotomy patients together and make comparison with 
other series difficult.87,96,97 Best survival in patients (47 %) who could not be 
weaned from cardiopulmonary bypass is reported by Ziomek.57 Overall 
necessity of ventricular assist device in this report is 6.8 %, a higher usage is 
reported by Raithel3,98 who found that 8.4 % of pediatric patients required 
ventricular assist device after cardiac surgery. The key to survival lies in the 
instution of ventricular assist device before severe organ damage can 
manifest.58 
Patients with incomplete repair of congenital heart disease do badly. Black 
reports 100 % mortality in this group.49 Therefore complete surgical repair 
should be a prerequisite for the implantation of a ventricular assist device. 
Patients who suffer otherwise untreatable cardiac arrest after cardiac surgery 
may benefit of the installation of a ventricular assist device more than other 
groups. Del Nido reported survival rates of 64 %.96,99 
The risk of embolic events remains a continuing concern. Formation of 
pseudo-intimas in the inflow conduit of ventricular assist devices was 
identified as a main source of embolism.100 The development of this friable, 
easily detachable neo-intima could be reduced by changes in physical 
characteristics of new inflow conduits: reduced compliance, elimination of 
graft crimp and shorter length. The dosage of anticoagulant medication must 
be adjusted to specific requirements of prolonged activation of biological 
coagulation cascades by using more biocompatible blood contacting surfaces. 
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Left ventricular venting to ensure complete decompression of the left heart is 
an important factor contributing to the patient's outcome. Ventricular 
overdistension can be minimized by maintenance of low central venous 
pressures and high flow rates.57 Otherwise left ventricular overdistension may 
result in elevation of left ventricular end-diastolic pressures when ventricular 
function is decreased and forward pulsatile flow is low. This may result in 
decreased coronary perfusion particularly of left ventricular subendocardial 
layers. In biventricular failure venting of the left ventricle is therefore 
advisable.62 
A possible key to success in circulatory support (with the exception of the 
bridge to transplant concept) with ventricular assist devices lies in the 
reversibility of heart dysfunction. Once myocardial architecture is destroyed, 
no support can regenerate myocardial tissue. Emplacement of a ventricular 
assist device reduces pre- and afterload, this reduction in left ventricular 
volume decreases wall stress during ventricular assist device support period 
and helps avoid cell damage and cell loss in cardiomyopathies.101 Unloading 
of the heart by using mechanical circulatory support appears to reverse 
pathological ventricular remodeling occuring in cardiomyopathies.102 It is 
crucial to install circulatory support via ventricular assist device in time before 
myocardial architecture deteriorates. 
Different assist devices can be combined, for example Biomedicus pump with 
intraaortic balloon pump to ensure pulsatile flow.59 Loss of pulsatility has been 
blamed for development of capillary leakage during prolonged pump runs.103 
In order to support children with severe cardiac dysfunction following open 
heart surgery,it is possible to use extracorporeal membrane oxygenation 
without oxygenator as so-called “no membrane oxygenator-ventricular assist 
device”.104 In this configuration, the circuit becomes a roller pump ventricular 
assist device. This system, as opposed to the centrifugal pump system, 
retains the desirable effects of extracorporeal membrane oxygenation 
including pump servo-regulation, pressure monitoring, access ports for 
fluid/drug administration, air bubble detection, in-line blood gas monitoring 
and heat exchanger. In patients with a single ventricle, for example after 
Norwood stage I procedure, oxygenation is provided by the children's own 
lungs by leaving aortopulmonary shunts open.105 
In a minority of patients, unloading of the left ventricle during left ventricular 
assist device allows a recovery of left ventricular function such that these 
patients can be weaned from circulatory assistance. In these selected patients 
ventricular assist device should not be a bridge to cardiac transplantation but 
rather to recovery. 
 
Future development 
The duration of circulatory support is extending continuously with the ultimate 
goal of total replacement of the heart. There is a growth in the number of 
patients with decompensated heart insufficiency in the adult and pediatric 
population, which cannot be sufficiently dealt with by heart transplants owing 
to the shortage of donor hearts. An alternative surgical solution could be 
extended use of ventricular assist devices as temporary or permanent 
implantation. 
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Children in advanced cardiac failure and in profound cardiogenic shock who 
would otherwise die immediately may be kept alive using ventricular assist 
devices and may either completely recover or qualify for successful heart 
transplantation. Widely used devices such as extracorporeal membrane 
oxygenation or other ventricular assist devices may sustain the circulation for 
several days or weeks. These systems require continuous intensive care, and 
chances for extubation and mobilization are very small. Pediatric ventricular 
assist devices should allow ambulation and rehabilitation of the patient. 
Rehabilitation is of vital importance in the adult and pediatric population. An 
implantable device of appropriate size would meet the needs of rehabilitation 
and ambulation. The aim is to design a device that could be used for long 
periods of time as a bridge to heart transplantation and with the possibility of 
its use as a permanent heart replacement device. 
The Jarvik 2000 is a potential device that could fulfill these criteria.72 The 
number of heart transplantations is limited due to shortage of donor hearts. In 
order to salvage patients suffering from severe end-stage cardiac diseases, 
artificial hearts as permanent implants may alleviate this problem. At the same 
time an increased number of transplant-contraindicated patients are fitted with 
circulation assist devices of a permanent kind. 
The possibility of having a new generation of systems so constructed to 
reduce the rate of complications, to minimize overall dimensions and to be 
easily managed (home care) should radically improve the risk-benefit ratio 
and economic concerns. However there are various problems to be solved: in 
addition to smaller, cheaper, simpler and more easily controllable pulsatile 
ventricular assist devices, there is a need for compact, durable and reliable 
nonpulsatile pumps, which can be completely implanted as a bridge to 
transplantation and/or for permanent use. 
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